fbpx
January 11, 2022

Super-Low Uric Acid May Not Be Best for Erosive Gout Super-Low Uric Acid May Not Be Best for Erosive Gout

Lowering the serum urate target to less than 0.20 mmol/L (<3.6 mg/dL) for patients with erosive gout does not achieve better gout outcomes and leads to […]
January 3, 2022

Pediatric Rheumatology Match Still Lags Behind Adult Results Pediatric Rheumatology Match Still Lags Behind Adult Results

Rheumatologists seeking fellowships continue to show a preference for adult programs. Adult rheumatology programs filled nearly 100% of positions this year, but pediatric rheumatology programs filled only 69% […]
December 23, 2021

FDA Approves Secukinumab (Cosentyx) for Pediatric Arthritis FDA Approves Secukinumab (Cosentyx) for Pediatric Arthritis

The US Food and Drug Administration (FDA) has approved secukinumab (Cosentyx, Novartis) for the treatment of active enthesitis-related arthritis (ERA) in children and adolescents age 4 years […]
December 16, 2021

Tofacitinib Approved for New Ankylosing Spondylitis Indication Tofacitinib Approved for New Ankylosing Spondylitis Indication

The US Food and Drug Administration (FDA) approved a supplemental new drug application for tofacitinib (Xeljanz, Xeljanz XR) that adds active ankylosing spondylitis in adults to […]
December 15, 2021

FDA Approves Upadacitinib (Rinvoq) for Psoriatic Arthritis FDA Approves Upadacitinib (Rinvoq) for Psoriatic Arthritis

The US Food and Drug Administration has approved a 15-mg extended release tablet of upadacitinib (Rinvoq) for adults with psoriatic arthritis who had an inadequate response […]
December 10, 2021

Alternative Rheumatology Practices Avoid Traditional Limitations Alternative Rheumatology Practices Avoid Traditional Limitations

Elizabeth Ortiz, MD, knew she needed a change. Working at an academic county clinic, she was often worn down and pulled in different directions. “When I […]
December 7, 2021

Peripheral Manifestations Influence Spondyloarthritis Trajectory Peripheral Manifestations Influence Spondyloarthritis Trajectory

Peripheral manifestations contribute significantly to disease activity in adults with spondyloarthritis (SpA), point toward a generally worse prognosis, and play a big role in defining the […]
December 2, 2021

Guselkumab Deemed Effective for PsA Previously Treated With TNFi Guselkumab Deemed Effective for PsA Previously Treated With TNFi

A new study has established guselkumab (Tremfya) as both a safe and effective treatment option for psoriatic arthritis (PsA) in patients who had previously responded poorly […]
November 29, 2021

Tofacitinib Yields Rapid and Sustained Improvement in JIA Tofacitinib Yields Rapid and Sustained Improvement in JIA

NEW YORK (Reuters Health) – Tofacitinib significantly reduces the number of flares in children with polyarticular course juvenile idiopathic arthritis (JIA), according to the first phase-3 […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0